Thursday, October 24, 2013
This week in techniques
Publication and contact
Major histocompatibility complex class I (MHC)-associated
phosphopeptides to predict clinical outcome in leukemia
phosphopeptides recognized by MHC could help predict outcomes for patients
with leukemia. The phosphopeptide repertoires from 11 tumor samples
representing multiple leukemia types were profiled for binding to MHC
molecules. In samples from patients with leukemia, immune responses to the
MHC-binding phosphopeptides were decreased compared with those of healthy
donors. Patients without immune responses to the phosphopeptides had
decreased survival compared with those who showed immune responses to the
phosphopeptides. Next steps include developing phosphopeptide antigens for
Inc. is developing therapeutics and diagnostics related to
Published online Oct. 24, 2013
Patented; licensed to
PhosImmune, a company spun-out of the University
of Virginia School of Medicine
Cobbold, M. et al. Sci.
Transl. Med.; published online Sept. 13, 2013;
Contact: Victor H. Engelhard, University of Virginia,
Contact: Mark Cobbold, University of Birmingham, Birmingham,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]